SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-031273
Filing Date
2024-03-06
Accepted
2024-03-06 07:12:11
Documents
16
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248059d1_8k.htm   iXBRL 8-K 25820
2 EXHIBIT 99.1 tm248059d1_ex99-1.htm EX-99.1 77677
6 GRAPHIC tm248059d1_ex99-1img001.jpg GRAPHIC 4918
  Complete submission text file 0001104659-24-031273.txt   298162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aplt-20240306.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20240306_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20240306_pre.xml EX-101.PRE 22381
17 EXTRACTED XBRL INSTANCE DOCUMENT tm248059d1_8k_htm.xml XML 3698
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 24724354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)